Hispanic People Have Unexplained Higher Risk For Nerve Disorder
By Dennis Thompson HealthDay Reporter
Medically reviewed by Drugs.com

FRIDAY, July 18, 2025 — Hispanic people are more likely to develop peripheral neuropathy than white people, and it’s not clear why, a new study has found.
Hispanic folks were 32% more likely than white people to have this nerve disorder even after accounting for known health, lifestyle and social risk factors, researchers reported July 16 in the journal Neurology.
“It is likely that unknown social risk factors exist for this population,” lead researcher Evan Lee Reynolds, an assistant professor at Michigan State University in East Lansing, said in a news release. “Identifying additional risk factors for Hispanic people should be the focus of future studies.”
Peripheral neuropathy occurs when nerves located outside the brain and spinal cord are damaged, according to the Mayo Clinic. People often feel weakness, numbness and pain, usually in the hands and feet.
“In the United States, there is a higher prevalence of peripheral neuropathy among Hispanic and Black people than white people, and the underlying factors driving these differences are not well defined,” Reynolds said.
For the study, researchers analyzed health records for more than 8,000 people, of whom 55% were white, 24% Hispanic and 18% Black. They had an average age of 61, and 13% had peripheral neuropathy.
The research team considered an array of risk factors for neuropathy, including:
In general, more people with neuropathy had diabetes, high blood pressure, larger waist circumference and lower income, results showed. They were also less active.
After adjusting only for age and sex, researchers found that both Hispanic and Black people had higher odds of peripheral neuropathy compared to white people.
Black people wound up with odds similar to those of white people after researchers accounted for all of the other risk factors.
But Hispanic people continued to have increased odds of peripheral neuropathy, even after all the other risks were included, the study found.
“We looked at a wide range of known risk factors, including health, lifestyle and social factors, and found that Hispanic people still had a higher risk of neuropathy even after those risk factors were considered,” Reynolds said.
Social factors weighed heavily in the known risks for peripheral neuropathy among Hispanic people, researchers said. For example, being uninsured increased their risk by 56%, and having food insecurity by 48%.
“Given the increasing percentage of Hispanic individuals in the United States, identifying the unmeasured risk factors of peripheral neuropathy among Hispanic individuals should be the focus of future observational studies,” researchers concluded.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-19 00:00
Read more

- Pierre Fabre Pharmaceuticals Inc. Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Tabelecleucel for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
- Association Found Between Home Mold, Hypersensitivity Pneumonitis
- Ritz Peanut Butter Crackers Recalled Over Labeling Mistake
- Johnson & Johnson Receives U.S. FDA Priority Review for TAR-200 NDA in High-Risk Non-Muscle Invasive Bladder Cancer
- Urgent Care Often Hands Out Inappropriate Prescriptions, Study Finds
- Alopecia Areata Associated With Severe Psychosocial Impact
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions